Unweighted Sample MDRO Concentration (CFU/100cm2) Mean and Median Overall and for Sets of Samples From CP and Control Rooms and by Zone
| Samples Included . | MRSA . | . | VRE . | . | C. difficile . | . |
|---|---|---|---|---|---|---|
| . | n . | Mean / Median . | n . | Mean / Median . | n . | Mean / Median . |
| All | 67 | 25.5 / 4.1 | 72 | 221.9 / 4.3 | 9 | 7.4 / 4.2 |
| CP rooms | 54 | 28.4 / 5.0 | 51 | 225.1 / 4.2 | 5 | 9.4 / 4.2 |
| Control rooms | 13 | 13.5 / 3.8 | 21 | 214.3 / 7.1 | 4 | 2.3 / 2.3 |
| Near-patient | 32 | 25.2 / 2.9 | 37 | 117.1 / 6.4 | 3 | 2.4 / 2.6 |
| Far-patient | 16 | 10.4 / 4.1 | 20 | 130.3 / 4.1 | 1 | NA |
| Bathroom | 19 | 38.7 / 8.5 | 15 | 589.4 / 8.5 | 5 | 11.2 / 5.3 |
| Samples Included . | MRSA . | . | VRE . | . | C. difficile . | . |
|---|---|---|---|---|---|---|
| . | n . | Mean / Median . | n . | Mean / Median . | n . | Mean / Median . |
| All | 67 | 25.5 / 4.1 | 72 | 221.9 / 4.3 | 9 | 7.4 / 4.2 |
| CP rooms | 54 | 28.4 / 5.0 | 51 | 225.1 / 4.2 | 5 | 9.4 / 4.2 |
| Control rooms | 13 | 13.5 / 3.8 | 21 | 214.3 / 7.1 | 4 | 2.3 / 2.3 |
| Near-patient | 32 | 25.2 / 2.9 | 37 | 117.1 / 6.4 | 3 | 2.4 / 2.6 |
| Far-patient | 16 | 10.4 / 4.1 | 20 | 130.3 / 4.1 | 1 | NA |
| Bathroom | 19 | 38.7 / 8.5 | 15 | 589.4 / 8.5 | 5 | 11.2 / 5.3 |
Abbreviations: CP, contact precautions; MRSA, methicillin-resistant Staphylococcus aureus; NA, not applicable; VRE, vancomycin-resistant enterococci.
Unweighted Sample MDRO Concentration (CFU/100cm2) Mean and Median Overall and for Sets of Samples From CP and Control Rooms and by Zone
| Samples Included . | MRSA . | . | VRE . | . | C. difficile . | . |
|---|---|---|---|---|---|---|
| . | n . | Mean / Median . | n . | Mean / Median . | n . | Mean / Median . |
| All | 67 | 25.5 / 4.1 | 72 | 221.9 / 4.3 | 9 | 7.4 / 4.2 |
| CP rooms | 54 | 28.4 / 5.0 | 51 | 225.1 / 4.2 | 5 | 9.4 / 4.2 |
| Control rooms | 13 | 13.5 / 3.8 | 21 | 214.3 / 7.1 | 4 | 2.3 / 2.3 |
| Near-patient | 32 | 25.2 / 2.9 | 37 | 117.1 / 6.4 | 3 | 2.4 / 2.6 |
| Far-patient | 16 | 10.4 / 4.1 | 20 | 130.3 / 4.1 | 1 | NA |
| Bathroom | 19 | 38.7 / 8.5 | 15 | 589.4 / 8.5 | 5 | 11.2 / 5.3 |
| Samples Included . | MRSA . | . | VRE . | . | C. difficile . | . |
|---|---|---|---|---|---|---|
| . | n . | Mean / Median . | n . | Mean / Median . | n . | Mean / Median . |
| All | 67 | 25.5 / 4.1 | 72 | 221.9 / 4.3 | 9 | 7.4 / 4.2 |
| CP rooms | 54 | 28.4 / 5.0 | 51 | 225.1 / 4.2 | 5 | 9.4 / 4.2 |
| Control rooms | 13 | 13.5 / 3.8 | 21 | 214.3 / 7.1 | 4 | 2.3 / 2.3 |
| Near-patient | 32 | 25.2 / 2.9 | 37 | 117.1 / 6.4 | 3 | 2.4 / 2.6 |
| Far-patient | 16 | 10.4 / 4.1 | 20 | 130.3 / 4.1 | 1 | NA |
| Bathroom | 19 | 38.7 / 8.5 | 15 | 589.4 / 8.5 | 5 | 11.2 / 5.3 |
Abbreviations: CP, contact precautions; MRSA, methicillin-resistant Staphylococcus aureus; NA, not applicable; VRE, vancomycin-resistant enterococci.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
